Immuron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.About IMRN
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.
CEOSteven Lydeamore
CEOSteven Lydeamore
Employees—
Employees—
HeadquartersBlackburn, Victoria (VIC)
HeadquartersBlackburn, Victoria (VIC)
Founded1994
Founded1994
Employees—
Employees—
IMRN Key Statistics
Market cap9.15M
Market cap9.15M
Price-Earnings ratio-2.83
Price-Earnings ratio-2.83
Dividend yield—
Dividend yield—
Average volume39.68K
Average volume39.68K
High today$0.986
High today$0.986
Low today$0.932
Low today$0.932
Open price$0.932
Open price$0.932
Volume7.10K
Volume7.10K
52 Week high$2.24
52 Week high$2.24
52 Week low$0.6765
52 Week low$0.6765
IMRN News
TipRanks 19h
Immuron Cuts U.S. ATM Offering Capacity to $2 Million in Updated F-3 FilingAn announcement from Immuron ( (IMRN) ) is now available. On October 23, 2026, Immuron Limited reported that it had reduced the capacity of its at-the-market e...
TipRanks 3d
Immuron CEO to Spotlight Oral Antibody Platform at Emerging Growth ConferenceImmuron Limited ( (AU:IMC) ) has shared an update. Immuron has announced that Chief Executive Officer Steven Lydeamore will deliver a virtual presentation at t...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.